ARTELO BIOSCIENCES, INC. Other Assets
ARTELO BIOSCIENCES, INC. (ARTL) had Other Assets of $3.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:OtherAssets · last filed 2026-08-12
- 2026-06-30: Other Assets $3.00K.
- 2026-03-31: Other Assets $3.00K.
- 2025-12-31: Other Assets $3.00K.
- 2025-09-30: Other Assets $3.00K.
| Period end | Other Assets |
|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $3.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $3.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $3.00K 8-K · filed 2025-07-11 |
| 2024-12-31 | $3.00K 8-K · filed 2026-03-17 |
| 2024-09-30 | $3.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $3.00K 8-K · filed 2025-07-11 |
| 2023-09-30 | $3.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $197.00K 10-Q · filed 2023-08-10 |
| 2022-12-31 | $3.00K 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |